1. Home
  2. DTIL vs BAFN Comparison

DTIL vs BAFN Comparison

Compare DTIL & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$6.38

Market Cap

128.8M

Sector

Health Care

ML Signal

HOLD

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$5.20

Market Cap

30.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTIL
BAFN
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
128.8M
30.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
DTIL
BAFN
Price
$6.38
$5.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
188.7K
9.1K
Earning Date
06-01-2026
04-30-2026
Dividend Yield
N/A
1.42%
EPS Growth
N/A
133.93
EPS
N/A
N/A
Revenue
$1,070,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.53
$5.23
52 Week High
$8.82
$19.00

Technical Indicators

Market Signals
Indicator
DTIL
BAFN
Relative Strength Index (RSI) 80.70 34.47
Support Level $4.50 N/A
Resistance Level $8.82 $8.37
Average True Range (ATR) 0.43 0.49
MACD 0.20 -0.11
Stochastic Oscillator 90.61 20.56

Price Performance

Historical Comparison
DTIL
BAFN

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: